"FIRST-IN-HUMAN" CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN. Issue 3 (September 2020) - Bernaldo-de-Quiros, Esther